Atopic Dermatitis: an Update and Review of the Literature

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 605-612

  Lipozenčić, Jasna ^a   Wolf, Ronni ^b,c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b HEBREW UNIVERSITY   (Israel)

^c KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEFACEPT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CALCINEURIN INHIBITOR; CEPHALOSPORIN; CORTICOSTEROID; CYCLOSPORIN A; EFALIZUMAB; EMOLLIENT AGENT; FUSIDIC ACID; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERFERON; INTERLEUKIN 12; MONTELUKAST; NERVE GROWTH FACTOR; OMALIZUMAB; RECOMBINANT GAMMA INTERFERON; STEROID; SUBSTANCE P; VALACICLOVIR; VASOACTIVE INTESTINAL POLYPEPTIDE; ZAFIRLUKAST;

ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE RELEASE; DOSE RESPONSE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; ENVIRONMENTAL FACTOR; HEREDITY; HISTOPATHOLOGY; HUMAN; KERATINOCYTE; MACROPHAGE; PATCH TEST; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW;

CYTOKINES; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; HUMANS; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTORS; PATCH TESTS; RECEPTORS, IGE; SKIN; T-LYMPHOCYTES;

EID: 34548846898     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.009     Document Type: Review

References (41)

1. Lipozenčić J., Bobek D., and Jakić Razumović J. The presence of surface CD30 on T cells in atopic dermatitis. Acta Dermatovenerol Croat 11 (2003) 145-152
2. Lugović L., Lipozenčić J., and Jakić Razumović J. Atopic dermatitis: immunophenotyping of inflammatory cells in skin lesions. Int J Dermatol 40 (2001) 489-494
3. Ring J., and Huss-Marp J. Atopic eczema. Karger Gazette (2004) 7-9
4. Schultz Larsen F., and Hanifin J.M. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 22 (2002) 1-24
5. Möhrenschlager M., Darsow U., Schnopp C., et al. Atopic eczema: what's new?. J Eur Acad Dermatol Venereol 20 (2006) 503-513
6. Fölster-Holst R., Steinsland K., Lange I., et al. Verlauf des eczema infantum. Hautarzt 50 Suppl 1 (1999) 108
7. Taieb A. The natural history of atopic dermatitis. J Am Acad Dermatol 45 (2001) S4-S6
8. Turner J.D., and Schwartz R.A. Atopic dermatitis. A clinical challenge. Acta Dermatovenerol Alp Panonica Adriat 15 (2006) 59-68
9. Eichenfield L., Hanifin J., Luger T., et al. ICCAD II faculty. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 49 (2003) 1088-1095
10. Akdis C.A., Akdis M., Bieber T., et al. European Academy of Allergology; Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. Allergy 61 (2006) 969-987
11. Hanifin J., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 92 (1980) 44-47
12. Williams H.C., Burney P.G., Pembroke A.C., et al. The UK working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 131 (1994) 406-416
13. Williams H.C., Burney P.G., Pembroke A.C., et al. Validation of UK diagnostic criteria for atopic dermatitis in a population setting. Br J Dermatol 135 (1996) 12-17
14. De D., Kanwar A.J., and Handa S. Comparative efficacy of Hanifin and Rajka's criteria and the UK working party's diagnostic criteria in diagnosis of atopic dermatitis in a hospital setting in North India. J Eur Acad Dermatol Venereol 20 (2006) 853-859
15. Johansson S.G., Hourihane J.O., Bousquet J., et al. EAACI (the European Academy of Allergology and Clinical Immunology) nomenclature task force. A revised nomenclature for allergy. An EAACI position statement from EAACI nomenclature task force. Allergy 56 (2001) 813-824
16. Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol 113 (2004) 832-836
17. Cookson W.O., Ubhi B., Lawrence R., et al. Genetic linkage of atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27 (2001) 372-373
18. Cookson W.O., and Moffatt M.F. The genetics of atopic dermatitis. Curr Opin Allergy Clin Immunol 2 (2002) 383-387
19. Tamura K., Suzuki M., Arakawa H., et al. Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int Arch Allergy Immunol 131 (2003) 33-38
20. Novak N., Kruse S., Kraft S., et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 119 (2002) 870-875
21. Weidinger S., Klopp N., Wagenpfeil S., et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 41 (2004) 658-663
22. Lugovic L., Lipozencic J., and Jakic-Razumovic J. Prominent involvement of activated Th1-subset of T-cells and increased expression of receptor for IFN-gamma on keratinocytes in atopic dermatitis acute skin lesions. Int Arch Allergy Immunol 137 (2005) 125-133
23. Schmid-Glendelmeier P., Fluckiger S., Disch R., et al. IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 115 (2005) 1068-1075
24. Hinz T., Staudacher A., and Bieber T. Neues in der Pathophysiologie der atopischen Dermatitis. Hautarzt 57 (2006) 567-574
25. Sayama K., Komatsuzawa H., Yamasaki K., et al. New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of beta-defensins, LL37, and TLR2. Eur J Immunol 35 (2005) 1886-1895
26. Lugović L., Lipozenčić J., and Jakić-Razumović J. The role of adhesion molecules in atopic dermatitis. Acta Dermatovenerol Croat 14 (2006) 2-7
27. Novak N., Bieber T., and Leung D.Y. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 112 (2003) S128-S139
28. Novak N., and Bieber T. Allergic and non-allergic forms of atopic disease. J Allergy Clin Immunol 112 (2003) 252-262
29. Sator P.G., Schmidt J.B., and Honigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 48 (2003) 352-358
30. Irvine A.D., and Mc Lean W.H.I. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 126 (2006) 1200-1202
31. Fuiano N., and Incorvaia C. Value of skin prick test and atopy patch test in mite-induced respiratory allergy and/or atopic eczema/dermatitis syndrome. Minerva Pediatr 56 (2004) 537-540
32. Nilsson C., Larsson A.K., Hoglind A., et al. Low numbers of interleukin-12-producing cord blood mononuclear cells and immunoglobulin E sensitization in early childhood. Clin Exp Allergy 34 (2004) 373-380
33. Echechipia S., Gomez B., Lasa E., et al. Epicutaneous test with inhalers in the study of atopic dermatitis. An Sist Sanit Navar 26 Suppl 2 (2003) 31-37
34. Berman B., De Araujo T., and Lebwohl M. Immunomodulators. In: Bolognia J.L., Jorizzo J.L., and Rapini R.P. (Eds). Dermatology (2003), Mosby, Edinburgh (Scotland) 2033-2053
35. Fonacier L., Spergel J., Charlesworth E.N., et al. Report of the topical calcineurin inhibitor task force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 115 (2005) 1249-1253
36. Spergel J.M., and Leung D.Y.M. Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence. Curr Allergy Asthma Rep 6 (2006) 270-274
37. Wahn U., Bos J.D., and Goodfield M. Flare reduction in eczema with lidel (children) Multicenter Investigator Study Group. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 110 1 Pt 1 (2002) e2
38. Foelster-Holst R., Nagel F., Zoellner P., et al. Efficacy of crisis intervention treatment with topical corticosteroid prednicarbate with and without partial wet-wrap dressing in atopic dermatitis. Dermatology 212 (2006) 66-69
39. Wolverton S., and Darst M. Systemic drugs. In: Bolognia J.L., Jorizzo J.L., and Rapini R.P. (Eds). Dermatology (2003), Mosby, Edinburgh (Scotland) 2071-2077
40. Scheinfeld N.S., Tutrone W.D., Weinberg J.M., et al. Phototherapy of atopic dermatitis. Clin Dermatol 21 (2003) 241-248
41. Scheinfeld N. Omalizumab: a recommbinat humanized monoclonal IgE-blocking antibody. Dermatol Online J 11 1 (2005) 2. http://dermatology.cdlib.org/111/reviews/omalizumab/scheinfeld.html Available at: